Found 6 matching trials
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer PHASE2 The aim of this study is to assess the potential benefit of the addition of...
Show More Location
Centre Hospitalier Universitaire Vaudois
Learn More & Join Trial
Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer PHASE1 This is a Phase 1b/2a, open-label, multi-center study to evaluate the safet...
Show More Learn More & Join Trial
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers PHASE2 This phase II trial studies how well deoxyribonucleic acid (DNA) plasmid-en...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients PHASE2 Combination immune checkpoint inhibitor and DNA vaccine will result in clea...
Show More Location
Johns Hopkins University
Learn More & Join Trial
Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma PHASE1 This is a Phase I/IIa, open-label study to evaluate the safety, tolerabilit...
Show More Location
University of Pennsylvania
Learn More & Join Trial
A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer PHASE1 This is an open-label study to evaluate the safety, tolerability, and immun...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial